Selecting an ophthalmology CRO is a risk decision, not just a vendor decision: sponsors are choosing how ocular endpoints will be protected across every site and visit. Most ophthalmology CROs...
Read More
Ophthalmology Clinical Trials: Strategic Growth, Scientific Innovation, and Execution Risk for Sponsors Key Takeaways Aging populations and chronic disease growth are expanding the patient pool for...
Read More
Transportation is not a soft, patient-experience issue in clinical trials. It's a protocol execution risk. When participants miss visits because getting to the site is difficult, timelines slip, data...
Read More
How to Reduce Patient Dropout Rates in Clinical Trials: Sponsor-Driven Retention Strategies That Protect Timelines Key Takeaways Dropout is a sponsor risk that impacts timelines, data continuity,...
Read More
BCVA, OCT, and IOP endpoints are rarely lost to one large failure. They're lost to small, repeated inconsistencies across sites: lighting that's "close enough," a slightly different approach to...
Read More
A decentralized clinical trial (DCT) platform is the technology stack that coordinates on-site and remote activity, connecting trial partners, vendors, and tools rather than replacing any of them....
Read More
At-home clinical trials have the potential to improve how research studies are conducted and the level of participation they receive. Learn more about this option and whether it’s appropriate for...
Read More